CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas

Julia Lüke1, Vlatka Vukoja2, Tim Brandenbusch2

  • 1Department of Ophthalmology, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany. Julia.lueke@uk-sh.de1.

BMC Ophthalmology
|June 4, 2016
PubMed
Abstract

Insights

Matrix-metalloproteinase (MMP) inducer CD147 may regulate MMP-2 expression in uveal melanoma cells. This study found CD147 up-regulation correlated with higher MMP-2 expression but not overall metastasis.

Area of Science:

  • Ophthalmology
  • Oncology
  • Molecular Biology

Background:

  • Extracellular matrix remodeling, driven by matrix-metalloproteinase (MMP) inducer CD147, is vital for tumor cell invasion and blood supply regulation.
  • Uveal melanoma is a significant intraocular malignancy where understanding invasion and metastasis is critical.

Purpose of the Study:

  • To investigate the correlation between CD147 and MMP-2 expression in uveal melanoma.
  • To assess the relationship of CD147 and MMP-2 expression with prognostic factors and vascularization in uveal melanoma.

Main Methods:

  • Analyzed CD147 and MMP-2 expression in 49 uveal melanoma samples using immunofluorescence.
  • Correlated expression levels with prognostic factors, vasculogenic mimicry, mature vasculature, and tumor-induced angiogenesis.
  • Utilized triple immunofluorescence staining with markers for glial cells (GFAP), endothelial cells (CD34), and macrophages (CD68) to determine CD147 and MMP-2 localization.

Main Results:

  • CD147 and MMP-2 were expressed in 96% of uveal melanomas, with CD147 up-regulation significantly correlating with higher MMP-2 expression.
  • No significant difference in CD147/MMP-2 expression was found between metastatic and non-metastatic groups.
  • In non-metastatic cases, clustered CD147-positive cells correlated with tumor size (basal diameter, height) and TNM stage.

Conclusions:

  • CD147 may regulate MMP-2 expression in uveal melanoma cells.
  • While CD147 and MMP-2 are prevalent, their expression levels do not directly correlate with overall metastatic disease in this cohort.
  • Specific patterns of CD147 expression in non-metastatic tumors are associated with established prognostic indicators.

Related Concept Videos